Press releaseBusiness Wire
Medifast
MED · NYSE
$12.06+$0.03 (+0.25%)TodayMarket closed ·
Prev close $12.03
Latest news
- Press releasePRNewswire
Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update
- Press releaseBusiness Wire
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™
- News
11 Consumer Staples Stocks Moving In Monday's After-Market Session
- News
Medifast Q2 Adj. EPS $(0.28) Beats $(0.65) Estimate, Sales $76.384M Beat $72.700M Estimate
- Press releaseBusiness Wire
Medifast Announces Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
- Press releaseBusiness Wire
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
- Press releaseBusiness Wire
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
- Press releaseBusiness Wire
Medifast Announces First Quarter 2026 Financial Results
- News
Earnings Scheduled For May 4, 2026
- News
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
- Press releaseBusiness Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026
- Press releasePRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Medifast, Inc. (NYSE: MED)
- Press releaseBusiness Wire
Medifast Announces Cooperation Agreement with Steamboat Capital
- Press releaseBusiness Wire
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
- News
Medifast Q4 2025 Earnings Call Transcript
- Press releaseBusiness Wire
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For February 17, 2026
- News
What to Expect from Medifast's Earnings
- Press releaseBusiness Wire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
- Press releasePRNewswire
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
- Press releaseBusiness Wire
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
- Press releaseBusiness Wire
OPTAVIA® Premieres Second Docuseries Episode "Health by Design: Spain" Exploring Metabolic Health and Longevity
- Press releaseBusiness Wire
Medifast Announces Planned Leadership Transition
- Press releaseBusiness Wire
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
- Press releaseBusiness Wire
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
- Press releaseBusiness Wire
Medifast Announces Third Quarter 2025 Financial Results
- Press releaseBusiness Wire
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
- Press releaseBusiness Wire
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
- Press releaseBusiness Wire
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
- Press releaseBusiness Wire
Medifast Announces Second Quarter 2025 Financial Results
- News
Uncovering Potential: Medifast's Earnings Preview
- NewsErica Kollmann
Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?
- Press releaseBusiness Wire
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
- Press releaseBusiness Wire
Medifast Announces Third Quarter 2024 Financial Results
- Press releaseBusiness Wire
Medifast Announces Second Quarter 2024 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.